Status:

COMPLETED

Before-after Comparison of Pharmacist Drug Therapy Management in Pediatric Hypertension

Lead Sponsor:

University of Louisiana Monroe

Collaborating Sponsors:

Ochsner Health System

Conditions:

Hypertension

Blood Pressure

Eligibility:

All Genders

4-20 years

Phase:

NA

Brief Summary

This study will measure the effect of a novel pharmacy practice model on pediatric patients with hypertension. In North Louisiana, many patients have to travel to see subspecialists for treatment for ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Diagnosis of elevated blood pressure or hypertension.
  • Physician decision to treat with drug therapy or lifestyle modifications and physician referral to pharmacist.
  • Consent both to therapy with pharmacist and participation in study (Note: in the state of Louisiana, patients must provide consent to be treated in a collaborative drug therapy management program).
  • For patients younger than 18, informed assent and parental permission to participate in the study. For patients who turn 18 during the study, informed consent will be obtained on the first visit after they turn 18.
  • Males and females; age 4-20 at enrollment
  • Willingness to adhere to study regimen
  • The same inclusion criteria will apply to control patients except that:
  • They will have been treated at the clinic for hypertension or elevated blood pressure during the control period.
  • A waiver of consent has been obtained for historical data.
  • Exclusion Criteria:
  • Physical preclusion to taking blood pressure, such as lack of limbs or any congenital or acquired anatomical defect preventing routine measurement of blood pressure
  • Participation in another treatment or intervention study for hypertension during the study period
  • Inability to speak English
  • For patients under 18 years old, not having at least one parent or guardian able to speak English
  • Patients who are pregnant

Exclusion

    Key Trial Info

    Start Date :

    January 14 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2021

    Estimated Enrollment :

    266 Patients enrolled

    Trial Details

    Trial ID

    NCT04098978

    Start Date

    January 14 2020

    End Date

    December 31 2021

    Last Update

    June 6 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ochsner Health Center for Children

    West Monroe, Louisiana, United States, 71292